Citadel Advisors’s DTRT Health Acquisition Corp. Warrant DTRTW Stock Holding History

Citadel Advisors’s Portfolio DTRTW Stock Details DTRTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-116,210	Closed	-$25.6K	–	16147
2022 Q4	$25.6K	Sell	116,210 -87,040	-43%	-$21K	﹤0.01%	12920
2022 Q3	$41K	Sell	203,250 -14,135	-7%	-$916	﹤0.01%	11754
2022 Q2	$13K	Sell	217,385 -582,645	-73%	-$81.2K	﹤0.01%	12535
2022 Q1	$168K	Buy	800,030 +30	+0%	+$10	﹤0.01%	11730
2021 Q4	$382K	Buy	+800,000	New	+$424K	﹤0.01%	10346

Citadel Advisors's DTRTW Position: Q1 2023 in Review

Citadel Advisors sold out of DTRT Health Acquisition Corp. Warrant (DTRTW) in Q1 2023, closing a stake of 116,210 shares — an estimated $25.6K sold.

Citadel Advisors first reported a position in DTRTW in Q4 2021 and held it in 5 quarters. The position peaked at $382K in Q4 2021. 0 funds tracked by Wall St. Rank hold DTRTW as of Q1 2023.

Citadel Advisors reported no remaining DTRT Health Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Citadel Advisors sold 116,210 DTRT Health Acquisition Corp. Warrant shares in Q1 2023, an estimated $25.6K.
Citadel Advisors first reported a position in DTRT Health Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
Citadel Advisors's DTRT Health Acquisition Corp. Warrant position peaked at $382K in Q4 2021.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Warrant as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.